We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.
Dec 19, 2016
Conatus Announces Exclusive Worldwide Option, Collaboration and License Agreement Covering Development and Commercialization of Emricasan
Nov 14, 2016
Events & Presentations
Dec 19, 2017 at 5:30 PM ET